Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case Series

por Feng, Shao, Qiang, Zhang, Wanwan, Cheng, Zhaozhun, Zeng, Yuewu, Xie, Shencun, Fang
Publicado 2022